Calithera Biosciences (CALA) Stock Chart & Stock Price History $0.0002 0.00 (0.00%) As of 09:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Calithera Biosciences Stock Price Performance The Calithera Biosciences (CALA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 80.00%, with a year-to-date return of 100.00%. As of the latest close, Calithera Biosciences traded at $0.00 with a market cap of $1 thousand and volume of 102 shares. Five years ago, the stock traded at a split-adjusted price of $84.40, representing a 100.00% decrease over that period. At the time, it had a market cap of $297.76 million and a volume of 581,187 shares. Receive CALA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%Year-To-Date Performance+100.00%1 Year Performance-80.00%5 Year Performance-100.00% CALA Stock Chart for Thursday, October, 16, 2025 CALA Chart by TradingView Calithera Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$0.00$0.00$0.00$0.00102 shs$1,000.0010/14/2025$0.00$0.00$0.00$0.0010 shs$1,000.0010/13/2025$0.00$0.00$0.00$0.00252 shs$1,000.0010/10/2025$0.00$0.00$0.00$0.00252 shs$1,000.0010/09/2025$0.00$0.00+100.00%$0.00$0.002,950 shs$1,000.0010/08/2025$0.00$0.00$0.00$0.00346 shs$0.0010/07/2025$0.00$0.00-83.33%$0.00$0.00346 shs$0.0010/06/2025$0.00$0.00+500.00%$0.00$0.002,272 shs$3,000.0010/03/2025$0.00$0.00$0.00$0.00307 shs$0.0010/02/2025$0.00$0.00$0.00$0.0010,462 shs$0.00 Get the Latest News and Ratings for CALA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$0.00$0.00$0.00$0.0055,134 shs$0.0009/30/2025N/A$0.00$0.00$0.00400 shs$0.0009/26/2025$0.00$0.00$0.00$0.00250 shs$0.0009/25/2025$0.00$0.00$0.00$0.00250 shs$0.0009/24/2025$0.00$0.00$0.00$0.00250 shs$0.0009/23/2025N/A$0.00$0.00$0.00130 shs$0.00 Related Companies ATNFW Stock Chart LBPSW Stock Chart AIMDW Stock Chart ALVOW Stock Chart ARAV Stock Chart ACABW Stock Chart BFRIW Stock Chart BTMDW Stock Chart BCTXW Stock Chart CELUW Stock Chart Receive CALA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CALA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calithera Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calithera Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
